295 related articles for article (PubMed ID: 35610611)
1. EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals.
Pilz MJ; Gamper EM; Efficace F; Arraras JI; Nolte S; Liegl G; Rose M; Giesinger JM;
BMC Public Health; 2022 May; 22(1):1040. PubMed ID: 35610611
[TBL] [Abstract][Full Text] [Related]
2. Normative data for the EORTC QLQ-C30 from the Austrian general population.
Lehmann J; Giesinger JM; Nolte S; Sztankay M; Wintner LM; Liegl G; Rose M; Holzner B;
Health Qual Life Outcomes; 2020 Aug; 18(1):275. PubMed ID: 32787854
[TBL] [Abstract][Full Text] [Related]
3. General Spanish population normative data analysis for the EORTC QLQ-C30 by sex, age, and health condition.
Arraras JI; Nolte S; Liegl G; Rose M; Manterola A; Illarramendi JJ; Zarandona U; Rico M; Teiejria L; Asin G; Hernandez I; Barrado M; Vera R; Efficace F; Giesinger JM;
Health Qual Life Outcomes; 2021 Aug; 19(1):208. PubMed ID: 34461909
[TBL] [Abstract][Full Text] [Related]
4. Updated normative data for the EORTC QLQ-C30 in the general Dutch population by age and sex: a cross-sectional panel research study.
de Ligt KM; Aaronson NK; Liegl G; Nolte S;
Qual Life Res; 2023 Sep; 32(9):2477-2487. PubMed ID: 37031427
[TBL] [Abstract][Full Text] [Related]
5. General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States.
Nolte S; Liegl G; Petersen MA; Aaronson NK; Costantini A; Fayers PM; Groenvold M; Holzner B; Johnson CD; Kemmler G; Tomaszewski KA; Waldmann A; Young TE; Rose M;
Eur J Cancer; 2019 Jan; 107():153-163. PubMed ID: 30576971
[TBL] [Abstract][Full Text] [Related]
6. The European Organisation for Research and Treatment of Cancer Quality of Life Utility-Core 10 Dimensions: Development and Investigation of General Population Utility Norms for Canada, France, Germany, Italy, Poland, and the United Kingdom.
Pilz MJ; Nolte S; Liegl G; King M; Norman R; McTaggart-Cowan H; Bottomley A; Rose M; Kemmler G; Holzner B; Gamper EM;
Value Health; 2023 May; 26(5):760-767. PubMed ID: 36572102
[TBL] [Abstract][Full Text] [Related]
7. Norwegian general population normative data for the European Organization for Research and Treatment of Cancer questionnaires: the Quality of Life Questionnaire-Core 30, the Sexual Health Questionnaire QLQ-SHQ22 and the sexual domains of the QLQ-BR23/BR45.
Åsberg RE; Nilsen M; Hjermstad MJ; Reinertsen KV; Karlsen J; Giskeødegård GF; Reidunsdatter RJ
Eur J Cancer; 2023 Sep; 190():112943. PubMed ID: 37515905
[TBL] [Abstract][Full Text] [Related]
8. Updated EORTC QLQ-C30 general population norm data for Germany.
Nolte S; Waldmann A; Liegl G; Petersen MA; Groenvold M; Rose M;
Eur J Cancer; 2020 Sep; 137():161-170. PubMed ID: 32777715
[TBL] [Abstract][Full Text] [Related]
9. The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values.
Mercieca-Bebber R; Costa DS; Norman R; Janda M; Smith DP; Grimison P; Gamper EM; King MT
Med J Aust; 2019 Jun; 210(11):499-506. PubMed ID: 31155722
[TBL] [Abstract][Full Text] [Related]
10. Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancer.
Musoro JZ; Coens C; Greimel E; King MT; Sprangers MAG; Nordin A; van Dorst EBL; Groenvold M; Cocks K; Velikova G; Flechtner HH; Bottomley A;
Gynecol Oncol; 2020 Nov; 159(2):515-521. PubMed ID: 32972782
[TBL] [Abstract][Full Text] [Related]
11. Danish population-based reference data for the EORTC QLQ-C30: associations with gender, age and morbidity.
Juul T; Petersen MA; Holzner B; Laurberg S; Christensen P; Grønvold M
Qual Life Res; 2014 Oct; 23(8):2183-93. PubMed ID: 24676897
[TBL] [Abstract][Full Text] [Related]
12. Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors.
Vachon H; Mierzynska J; Taye M; Pe M; Coens C; Martinelli F; Fortpied C; Flechtner HH; Vestmoe Maraldo M; Hutchings M; Meijnders P; Aleman B; Lugtenburg P; Spina M; André M; Hertzberg M; Briones J; Bottomley A;
Eur J Haematol; 2021 May; 106(5):697-707. PubMed ID: 33570765
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract][Full Text] [Related]
14. Comparison between Swedish EORTC QLQ-C30 general population norm data published in 2000 and 2019.
Johansson H; Lagergren P; Nolte S; Brandberg Y
Acta Oncol; 2023 Dec; 62(12):1592-1598. PubMed ID: 37862371
[TBL] [Abstract][Full Text] [Related]
15. Normative data of the EORTC QLQ-C30 for the German population: a population-based survey.
Waldmann A; Schubert D; Katalinic A
PLoS One; 2013; 8(9):e74149. PubMed ID: 24058523
[TBL] [Abstract][Full Text] [Related]
16. Minimally important differences for interpreting the EORTC QLQ-C30 in patients with advanced colorectal cancer treated with chemotherapy.
Musoro JZ; Sodergren SC; Coens C; Pochesci A; Terada M; King MT; Sprangers MAG; Groenvold M; Cocks K; Velikova G; Flechtner HH; Bottomley A;
Colorectal Dis; 2020 Dec; 22(12):2278-2287. PubMed ID: 32767619
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in Colombia: reference values of the EORTC QLQ-C30.
Finck C; Barradas S; Singer S; Zenger M; Hinz A
Eur J Cancer Care (Engl); 2012 Nov; 21(6):829-36. PubMed ID: 22966808
[TBL] [Abstract][Full Text] [Related]
18. Establishing the European Norm for the health-related quality of life domains of the computer-adaptive test EORTC CAT Core.
Liegl G; Petersen MA; Groenvold M; Aaronson NK; Costantini A; Fayers PM; Holzner B; Johnson CD; Kemmler G; Tomaszewski KA; Waldmann A; Young TE; Rose M; Nolte S;
Eur J Cancer; 2019 Jan; 107():133-141. PubMed ID: 30576969
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients.
Apolone G; Filiberti A; Cifani S; Ruggiata R; Mosconi P
Ann Oncol; 1998 May; 9(5):549-57. PubMed ID: 9653497
[TBL] [Abstract][Full Text] [Related]
20. Reference data of the EORTC QLQ-C30 questionnaire: five consecutive annual assessments of approximately 2000 representative Dutch men and women.
Mols F; Husson O; Oudejans M; Vlooswijk C; Horevoorts N; van de Poll-Franse LV
Acta Oncol; 2018 Oct; 57(10):1381-1391. PubMed ID: 29912607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]